| |
| |
|
| Insider
Information: |
Goldan Keith A. |
| Relationship: |
|
| City: |
Conshohocken |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
195,099 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,209,836 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
195,099 |
|
|
| Total
Value |
$1,209,836 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -5.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fibrocell Science Inc |
FCSC |
SVP and CFO |
2015-08-11 |
2,000 |
2015-08-11 |
0 |
Premium* |
|
|
Optinose Inc |
OPTN |
Chief Financial Officer |
2022-03-16 |
141,726 |
2019-06-28 |
0 |
Premium* |
|
|
Syndax Pharmaceuticals Inc |
SNDX |
|
2024-02-07 |
51,373 |
2022-06-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SNDX |
Syndax Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
46,700 |
51,373 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2024-01-31 |
4 |
A |
$17.42 |
$20,608 |
D/D |
1,183 |
4,673 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2023-07-31 |
4 |
A |
$18.12 |
$15,619 |
D/D |
862 |
3,490 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2023-06-13 |
4 |
S |
$22.31 |
$12,873 |
D/D |
(577) |
2,628 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2022-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,205 |
3,205 |
0 |
- |
|
| OPTN |
Optinose Inc |
Chief Financial Officer |
• – – |
2022-03-16 |
4 |
S |
$2.11 |
$9,742 |
D/D |
(4,617) |
141,726 |
0 |
% |
|
| OPTN |
Optinose Inc |
Chief Financial Officer |
• – – |
2022-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
56,730 |
146,343 |
0 |
- |
|
| OPTN |
Optinose Inc |
Chief Financial Officer |
• – – |
2021-12-16 |
4 |
S |
$1.64 |
$951 |
D/D |
(580) |
89,613 |
0 |
% |
|
| OPTN |
Optinose Inc |
Chief Financial Officer |
• – – |
2021-09-16 |
4 |
S |
$2.79 |
$1,612 |
D/D |
(578) |
90,193 |
0 |
% |
|
| OPTN |
Optinose Inc |
Chief Financial Officer |
• – – |
2021-06-17 |
4 |
S |
$3.73 |
$2,148 |
D/D |
(576) |
90,771 |
0 |
% |
|
| OPTN |
Optinose Inc |
Chief Financial Officer |
• – – |
2021-03-15 |
4 |
S |
$3.92 |
$9,032 |
D/D |
(2,304) |
91,347 |
0 |
% |
|
| OPTN |
Optinose Inc |
Chief Financial Officer |
• – – |
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
53,333 |
63,084 |
0 |
- |
|
| OPTN |
Optinose Inc |
Chief Financial Officer |
• – – |
2020-09-23 |
4 |
B |
$3.90 |
$9,743 |
D/D |
2,500 |
9,751 |
2.74 |
% |
|
| OPTN |
Optinose Inc |
Chief Financial Officer |
• – – |
2020-03-06 |
4/A |
A |
$0.00 |
$0 |
D/D |
30,567 |
37,328 |
0 |
- |
|
| OPTN |
Optinose Inc |
Chief Financial Officer |
• – – |
2019-06-28 |
4 |
A |
$5.64 |
$5,307 |
D/D |
941 |
4,066 |
0 |
- |
|
| FCSC |
Fibrocell Science Inc |
SVP and CFO |
• – – |
2015-08-11 |
4 |
B |
$6.33 |
$12,660 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
